US05479K1060 - Common Stock
AZIYO BIOLOGICS INC-CLASS A
NASDAQ:AZYO (9/6/2023, 7:00:01 PM)
1.49
+0.03 (+2.05%)
Aziyo Biologics, Inc. operates as a biotechnology company. The company is headquartered in Silver Spring, Maryland and currently employs 151 full-time employees. The company went IPO on 2020-10-08. The firm has developed a portfolio of regenerative products using both human and porcine tissue that are designed to be as close to natural biological material. The firm operates in four segments: Device Protection, Women's Health, Orthobiologics, and Cardiovascular. Its product portfolio includes CanGaroo, SimpliDerm, ViBone, OsteGro V, Fiber VBM, ProxiCor, Tyke, and VasCure. These products are primarily sold to healthcare providers or commercial partners. In device protection, it sells biological envelopes that form a natural, systemically vascularized pocket for holding implanted electronic devices. In cardiovascular, the Company sells its specialized porcine small intestine submucosa (SIS ECM) for use as an intracardiac and vascular patch. The company also sells human tissue products under contract manufacturing and other arrangements with corporate customers.
AZIYO BIOLOGICS INC-CLASS A
12510 Prosperity Drive, Suite 370
Silver Spring MARYLAND 20904
P: 12402471143.0
CEO: Ronald Lloyd
Employees: 151
Website: https://www.aziyo.com/
SILVER SPRING, Md., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today...
Case provides first histologic evidence that CanGaroo can catalyze development of new healthy tissue layer within an existing cardiac implantable...
Negotiating multiple LOIs to divest Orthopedic business CanGaroo® RM 510(k) resubmission to the FDA remains on track SimpliDerm® quarterly net sales up...
SILVER SPRING, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic...
/PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and...
Aziyo Biologics (AZYO) is recalling its viable bone matrix products after two patients developed an infection. Read more here.
Here you can normally see the latest stock twits on AZYO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: